Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus

Yanick J Crow, Bruce E Hayward, Rekha Parmar, Peter Robins, Andrea Robertson (nee Leitch), Manir Ali, Deborah N Black, Hans van Bokhoven, Han G Brunner, Ben C Hamel, Peter C Corry, Frances M Cowan, Suzanne G Frints, Joerg Klepper, John H Livingston, Sally Ann Lynch, Roger F Massey, Jean François Meritet, Jacques L Michaud, Gerard PonsotThomas Voit, Pierre Lebon, David T Bonthron, Andrew P Jackson, Deborah E Barnes, Tomas Lindahl

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Aicardi-Goutières syndrome (AGS) presents as a severe neurological brain disease and is a genetic mimic of the sequelae of transplacentally acquired viral infection. Evidence exists for a perturbation of innate immunity as a primary pathogenic event in the disease phenotype. Here, we show that TREX1, encoding the major mammalian 3' --> 5' DNA exonuclease, is the AGS1 gene, and AGS-causing mutations result in abrogation of TREX1 enzyme activity. Similar loss of function in the Trex1(-/-) mouse leads to an inflammatory phenotype. Our findings suggest an unanticipated role for TREX1 in processing or clearing anomalous DNA structures, failure of which results in the triggering of an abnormal innate immune response.
Original languageEnglish
Pages (from-to)917-20
Number of pages4
JournalNature Genetics
Volume38
Issue number8
DOIs
Publication statusPublished - 2006

Fingerprint

Dive into the research topics of 'Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus'. Together they form a unique fingerprint.

Cite this